S. 142 · 118th Congress

Preserve Access to Affordable Generics and Biosimilars Act

Stage: Reported from committee
Sponsor: Amy Klobuchar
Introduced: 2023-01-30
Latest action: 2023-03-01 · Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

Subjects

Administrative law and regulatory procedures

Health

Civil actions and liability

Licensing and registrations

Intellectual property

Prescription drugs

Marketing and advertising

Competition and antitrust

Manufacturing

Judicial review and appeals

Contracts and agency

Federal Trade Commission (FTC)